{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:22:41Z","timestamp":1781648561562,"version":"3.54.5"},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1629,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1469-8749.2011.03952.x","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T12:28:00Z","timestamp":1300364880000},"page":"559-564","source":"Crossref","is-referenced-by-count":38,"title":["Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses"],"prefix":"10.1111","volume":"53","author":[{"given":"MARIO","family":"BASCIANI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FILOMENA","family":"DI RIENZO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDREA","family":"FONTANA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASSIMILIANO","family":"COPETTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FABIO","family":"PELLEGRINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DOMENICO","family":"INTISO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,17]]},"reference":[{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.braindev.2009.03.009","article-title":"Cerebral palsy update","volume":"31","author":"Krageloh-Mann","year":"2009","journal-title":"Brain Dev"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/000992289803700805","article-title":"Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy","volume":"37","author":"Bachrach","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1345\/aph.1C019","article-title":"Sialorrhea - therapeutic drug options","volume":"36","author":"Tscheng","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1469-8749.2002.tb00286.x","article-title":"Management of drooling: 10 years after the Consortium on Drooling, 1990","volume":"44","author":"Blasco","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1017\/S0012162201000718","article-title":"Management of drooling in individuals with neurodisability: a surgical experience","volume":"43","author":"Crysdale","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0887-8994(02)00381-8","article-title":"Botulinum toxin A as a treatment for excessive drooling in children","volume":"27","author":"Bothwell","year":"2002","journal-title":"Pediatr Neurol"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","article-title":"A randomized trial of botulinum toxin A for the treatment of drooling","volume":"61","author":"Lipp","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.PHM.0000104680.28335.B9","article-title":"Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy","volume":"83","author":"Savarese","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.0012-1622.2008.02010.x","article-title":"Randomized trial of botulinum toxin injections into salivary glands to reduce drooling in children with neurological disorders","volume":"50","author":"Reid","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/01.wnl.0000300421.38081.7d","article-title":"Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy","volume":"70","author":"Lin","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clineuro.2008.09.001","article-title":"Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial","volume":"111","author":"Alrefai","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson\u2019s disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00415-009-0085-1","article-title":"Long-lasting benefits of botulinum toxin type B in Parkinson\u2019s disease-related drooling","volume":"256","author":"Lagalla","year":"2009","journal-title":"J Neurol"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00415-008-0738-5","article-title":"Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis","volume":"255","author":"Costa","year":"2008","journal-title":"J Neurol"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients","volume":"39","author":"Jackson","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00213-009-1689-y","article-title":"Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea","volume":"207","author":"Steinlechner","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0028-1112115","article-title":"Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B","volume":"39","author":"Wilken","year":"2008","journal-title":"Neuropediatrics"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02412423","article-title":"Three treatment approaches and clinical factors in the reduction of drooling","volume":"3","author":"Thomas-Stonell","year":"1988","journal-title":"Dysphagia"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S0012162206000235","article-title":"Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care","volume":"48","author":"Van der Burg","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1469-8749.1994.tb11877.x","article-title":"Transdermal scopolamine for reduction of drooling in developmentally delayed children","volume":"36","author":"Lewis","year":"1994","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1469-8749.1990.tb08121.x","article-title":"Use of benzhexol hydrochloride to control drooling of children with cerebral palsy","volume":"32","author":"Reddihough","year":"1990","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000067023","article-title":"Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis","volume":"49","author":"Dressler","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1212\/WNL.59.9.1445","article-title":"Ptosis as a remote effect of therapeutic botulinum toxin B injection","volume":"59","author":"Racette","year":"2002","journal-title":"Neurology"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/01.wnl.0000174433.76707.8c","article-title":"Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial","volume":"65","author":"Tintner","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/j.1469-8749.2011.03952.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1017\/S0012162207000151.x","article-title":"Secondary non-response due to antibodies formation in a child after three injections of botulinum toxin B into salivary glands","volume":"49","author":"Berweck","year":"2007","journal-title":"Dev Med Child Neurol"}],"container-title":["Developmental Medicine & Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1469-8749.2011.03952.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1469-8749.2011.03952.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T20:50:59Z","timestamp":1612644659000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1469-8749.2011.03952.x"}},"subtitle":["BoNT-B in Children with CP and Sialorrhoea"],"short-title":[],"issued":{"date-parts":[[2011,3,17]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1469-8749.2011.03952.x","relation":{},"ISSN":["0012-1622"],"issn-type":[{"value":"0012-1622","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,17]]}}}